Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMGO Imago Bio Sciences, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
IMRA Imara Inc.	$552M	$0 0.0% of portfolio	0	Q4 2024 New
IMTX Immatics N.V.	$353M	$0 0.0% of portfolio	0	Q4 2024 New
IMMX Immix Biopharma, Inc.	$23.6M	$0 0.0% of portfolio	0	Q4 2024 New
ICCC Immucell Corp	$38.8M	$0 0.0% of portfolio	0	Q4 2024 New
IMRX Immuneering Corp	$42.8M	$0 0.0% of portfolio	0	Q4 2024 New
IMUX Immunic, Inc.	$36.7M	$0 0.0% of portfolio	0	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.26B	$0 0.0% of portfolio	0	Q4 2024 New
IMCR Immunocore Holdings PLC	$1.3B	$0 0.0% of portfolio	0	Q4 2024 New
IMNM Immunome Inc.	$84.8M	$0 0.0% of portfolio	0	Q4 2024 New
IPA Immuno Precise Antibodies Ltd.	$9.69M	$0 0.0% of portfolio	0	Q4 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	0	Q4 2024 New
IMRN Immuron Limited	$11.8M	$0 0.0% of portfolio	-	Q4 2024 New
IMMP Immutep LTD	$158M	$0 0.0% of portfolio	0	Q4 2024 New
INAB In8 Bio, Inc.	$4.9M	$0 0.0% of portfolio	0	Q4 2024 New
INDP Indaptus Therapeutics, Inc.	$4.87M	$0 0.0% of portfolio	0	Q4 2024 New
IFRX Infla Rx N.V.	$50.8M	$0 0.0% of portfolio	0	Q4 2024 New
INMB Inmune Bio, Inc.	$134M	$0 0.0% of portfolio	0	Q4 2024 New
IPHA Innate Pharma Sa	$158M	$0 0.0% of portfolio	0	Q4 2024 New
INVA Innoviva, Inc.	$1.27B	$0 0.0% of portfolio	0	Q4 2024 New
INZY Inozyme Pharma, Inc.	$36.9M	$0 0.0% of portfolio	0	Q4 2024 New
INSM Insmed Inc	$10.6B	$0 0.0% of portfolio	0	Q4 2024 New
IVA Inventiva S.A.	$123M	$0 0.0% of portfolio	0	Q4 2024 New
IOBT Io Biotech, Inc.	$34.6M	$0 0.0% of portfolio	0	Q4 2024 New
IONS Ionis Pharmaceuticals Inc	$4.42B	$0 0.0% of portfolio	0	Q4 2024 New
IOVA Iovance Biotherapeutics, Inc.	$562M	$0 0.0% of portfolio	0	Q4 2024 New
ITOS I Teos Therapeutics, Inc.	$225M	$0 0.0% of portfolio	0	Q4 2024 New
JAGX Jaguar Health, Inc.	$599M	$0 0.0% of portfolio	0	Q4 2024 New
JANX Janux Therapeutics, Inc.	$1.21B	$0 0.0% of portfolio	0	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$294M	$0 0.0% of portfolio	0	Q4 2024 New
KPTI Karyopharm Therapeutics Inc.	$332M	$0 0.0% of portfolio	0	Q4 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	0	Q4 2024 New
KROS Keros Therapeutics, Inc.	$278M	$0 0.0% of portfolio	0	Q4 2024 New
KRBP Kiromic Biopharma, Inc.	$1.9M	$0 0.0% of portfolio	0	Q4 2024 New
KOD Kodiak Sciences Inc.	$151M	$0 0.0% of portfolio	0	Q4 2024 New
KRON Kronos Bio, Inc.	$46.6M	$0 0.0% of portfolio	0	Q4 2024 New
KRYS Krystal Biotech, Inc.	$4.72B	$0 0.0% of portfolio	0	Q4 2024 New
KURA Kura Oncology, Inc.	$472M	$0 0.0% of portfolio	0	Q4 2024 New
KYMR Kymera Therapeutics, Inc.	$1.62B	$0 0.0% of portfolio	0	Q4 2024 New
LTRN Lantern Pharma Inc.	$38.4M	$0 0.0% of portfolio	0	Q4 2024 New
LRMR Larimar Therapeutics, Inc.	$102M	$0 0.0% of portfolio	0	Q4 2024 New
LVTX Lava Therapeutics Nv	$33.3M	$0 0.0% of portfolio	0	Q4 2024 New
LEGN Legend Biotech Corp	$5.87B	$0 0.0% of portfolio	0	Q4 2024 New
LEXX Lexaria Bioscience Corp.	$10.2M	$0 0.0% of portfolio	0	Q4 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$108M	$0 0.0% of portfolio	0	Q4 2024 New
LMNL Liminal Bio Sciences Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$83.2M	$0 0.0% of portfolio	0	Q4 2024 New
LQDA Liquidia Corp	$971M	$0 0.0% of portfolio	0	Q4 2024 New
LYEL Lyell Immunopharma, Inc.	$134M	$0 0.0% of portfolio	0	Q4 2024 New
LYRA Lyra Therapeutics, Inc.	$4.46M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.